Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TRICALS platform trial of lithium carbonate in amyotrophic lateral sclerosis
ISRCTN15671139Phase 3Completed
- Sponsor
- TRICALS
- Start
- Jun 2021
- Modality
- DNA Intercalators/Alkylators → Nucleic Acid-Directed Small Molecules → Small Molecules
01
Overview
Phase 3, randomised, double-blind trial in amyotrophic lateral sclerosis (ALS) comparing Lithium carbonate with Placebo (2 arms). Primary endpoint: Overall survival. Started Jun 2021; status: completed.
02
Drugs
lithium carbonate
03
Conditions
amyotrophic lateral sclerosis (ALS)
Beyond the preview
Go deeper on ISRCTN15671139.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ISRCTN15671139.